BYSI

BeyondSpring Stock Price

15.22
-0.60 (-3.79%)
Upgrade to Real-Time
Afterhours (Closed)
15.22

Low
8.90

52 Week Range

High
33.00

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
BeyondSpring Inc BYSI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.60 -3.79% 15.22 19:28:10
Open Price Low Price High Price Close Price Prev Close
15.73 15.06 16.32 15.15 15.82
Bid Price Ask Price Spread News
15.22 15.50 0.28 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
10,041 1,328,918 $ 15.66 $ 20,812,906 - 8.90 - 33.00
Last Trade Time Type Quantity Stock Price Currency
19:59:57 10 $ 15.50 USD

Period:

Draw Mode:

BeyondSpring Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 464.10M 30.49M 10.96M $ 180.00k $ - -2.41 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - -

more financials information »

BeyondSpring News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BYSI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week22.4723.4914.7117.562,071,624-7.25-32.27%
1 Month24.5133.0014.7124.752,088,214-9.29-37.9%
3 Months10.5933.008.9025.303,623,1654.6343.72%
6 Months12.7733.008.9024.441,744,1442.4519.19%
1 Year14.1233.008.9022.531,045,1441.107.79%
3 Years25.1633.008.9021.81387,766-9.94-39.51%
5 Years20.0048.498.9021.87260,713-4.78-23.9%

BeyondSpring Description

BeyondSpring Inc is engaged in clinical stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. The Company has created Plinabulin which is marine derived small-molecule with a number of distinct biological activities that may provide multiple therapeutic opportunities. Plinabulin has increased the survival of neutrophils, a type of white blood cell important in the prevention of bacterial infections. The Company has a scalable business model integrating clinical resources in the United States and China.
Your Recent History
NASDAQ
BYSI
BeyondSpri..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210923 00:16:17